Skip to main content
RUO Limitless Life Nootropics — free shipping on orders over $200 · Same-day USA dispatch.
Home Shop A-Z
Shop by Research Category
Shop by Type
Cart Checkout FAQs Contact Us Blog Call (813) 203-3466

AOD9604 Peptide

Price range: $49.00 through $140.00

Research-grade AOD9604 is a 16-amino-acid synthetic fragment (Tyr-hGH177-191) of the C-terminal lipolytic domain of human growth hormone (hGH).

SKU: aod9604 Category: Tags: , , , ,

Discount per Quantity

Quantity 5 – 9 10 +
Discount 5% 10%
Price $46.55 $44.10

Orders over $200: FREE USPS Priority shipping.

  • >99% purity — HPLC + MS verified
  • Cold-pack insulated mailers
  • Discreet US shipping (2–5 days)
  • COA available on request

Research Use Only. Not for human consumption. Sold strictly for laboratory and research use.

For Research Use Only. Not for human use.

AOD9604 is a modified analogue of the hGH C-terminal fragment (residues 177–191 with N-terminal tyrosine addition and disulfide cyclisation), first synthesized in the 1990s by Metabolic Pharmaceuticals. It has been studied for its selective stimulation of lipolysis via beta-3 adrenergic receptor upregulation in adipose tissue without elevating IGF-1 or producing hGH-like anabolic side effects. This research-grade lyophilized powder is synthesized under strict quality controls and includes full analytical documentation, making it suitable for metabolic, lipolytic, and cartilage repair research applications.

Key Scientific Features

  • High-purity AOD9604 (≥ 98% by HPLC/MS, cyclized acetate salt form)
  • Verified 16-amino-acid sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe (disulfide bridge between Cys7–Cys14)
  • Lyophilized formulation for enhanced long-term stability
  • Full Certificate of Analysis (COA) with HPLC, MS, and amino acid analysis
  • Manufactured in GMP-aligned, ISO-compliant facilities
  • Suitable for lipolytic assays, beta-3 AR modulation studies, and osteoarthritis research

Research-Referenced Attributes (Based on scientific literature; not intended as therapeutic claims.)

  • Stimulates lipolysis and fat oxidation via beta-3 adrenergic receptor upregulation in adipose tissue in preclinical models
  • Modulates lipid profiles in obese rodent models without IGF-1 elevation
  • Investigated for cartilage repair and osteoblast stimulation in preclinical research settings
  • No genotoxic, mutagenic, or diabetogenic effects observed in preclinical safety studies
  • Studied in metabolic syndrome and NAFLD preclinical research models

Why Researchers Choose Nationwide Peptides AOD9604

  • Exact clinical-sequence match with tyrosine addition and disulfide cyclization
  • Consistent potency and batch-to-batch reproducibility
  • Transparent analytical data (HPLC >98%, MS confirmation)
  • Trusted by metabolic endocrinology, lipolysis, and orthopedics research laboratories
  • Competitive research pricing with bulk options

Frequently bought together

Reviews

There are no reviews yet.

Be the first to review “AOD9604 Peptide”

Your email address will not be published. Required fields are marked *